GlassScriptPhysician profile
Amber H Iqbal
NPI 1124396254
$1,719.83
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,175 · 2020: $251 · 2021: $177 · 2022: $20.07 · 2023: $97.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $97.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $97.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $169.06 | 2019-2023 | Opdivo |
| Servier Pharmaceuticals LLC | $159.26 | 2021 | |
| Janssen Biotech, INC. | $140.42 | 2019-2023 | Imbruvica |
| Genentech USA, INC. | $116.23 | 2019 | |
| Incyte Corporation | $109.04 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $106.95 | 2019 | |
| Alexion Pharmaceuticals, INC. | $100.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $99.00 | 2019 | |
| Seagen INC. | $95.45 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $66.03 | 2019-2020 | |
| Pfizer INC. | $61.50 | 2019 | |
| Eisai INC. | $59.61 | 2019 | |
| Taiho Oncology, INC. | $53.52 | 2019-2020 | |
| Celgene Corporation | $52.11 | 2019 | |
| Amgen INC. | $39.89 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $38.73 | 2019-2023 | Verzenio |
| Astellas Pharma US INC | $37.47 | 2019-2020 | |
| Foundation Medicine, INC. | $34.58 | 2019-2020 | |
| Tesaro, INC. | $32.37 | 2019 | |
| Abbvie INC. | $29.02 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.84 | 2019 | |
| Sobi, INC | $21.83 | 2023 | |
| Emd Serono, INC. | $16.38 | 2020 | |
| Clovis Oncology, INC. | $15.77 | 2019 | |
| Daiichi Sankyo INC. | $15.13 | 2020 | |
| Exelixis INC. | $14.84 | 2019 | |
| Fortovia Therapeutics, INC. | $9.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.